Several novel AKI biomarkers have been identified including neutrophil gelatinase–associated lipocalin (NGAL), kidney injury molecule 1 (KIM-1), cystatin C, interleukin (IL)-18, and liver-type fatty acid–binding protein [14–17]. Here, LCN2 is linked to acute kidney injury.